Regeneron Financial Statements (REGN)

Regeneronsmart-lab.ru   2021 2022 2023 2024 2025   LTM ?
Report date 07.02.2022 06.02.2023 05.02.2024 05.02.2025 04.02.2026   29.04.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 16 072 12 173 13 117 14 202 14 343   14 920
Operating Income, bln rub 8 947 5 386 4 349 3 991 3 578   3 629
EBITDA, bln rub ? 9 669 5 260 4 693 5 318 5 818   5 745
Net profit, bln rub ? 8 075 4 338 3 954 4 413 4 505   4 423
OCF, bln rub ? 7 081 5 015 4 594 4 421 4 979   5 013
CAPEX, bln rub ? 551.9 590.1 926.4 755.9 898.4   857.5
FCF, bln rub ? 6 529 4 425 3 668 3 665 4 081   4 155
Dividend payout, bln rub 0.000 0.000 0.000 0.000 370.3   374.3
Ordinary share dividend yield, % 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 8.22%   8.46%
OPEX, bln rub 4 401 5 082 6 524 8 241 8 664   8 985
Cost of production, bln rub 2 724 1 705 2 245 1 971 2 101   2 306
R&D, bln rub 2 622 3 056 3 987 5 233 5 850   6 261
Interest expenses, bln rub 57.3 59.4 73.0 55.2 43.8   48.0
Assets, bln rub 25 435 29 215 33 080 37 759 40 559   40 869
Net Assets, bln rub ? 18 769 22 664 25 973 29 354 31 257   31 424
Debt, bln rub 2 700 2 701 2 703 2 704 2 706   2 706
Cash, bln rub 5 695 7 742 10 845 9 013 8 605   8 754
Net debt, bln rub -2 995 -5 041 -8 142 -6 308 -5 899   -6 048
Ordinary share price, rub 631.5 712.3 771.9   638.9
Number of ordinary shares, mln 105.7 107.1 106.7 107.9 104.6   104.0
Market cap, bln rub 66 752 0 0 76 860 80 738   66 444
EV, bln rub ? 63 757 -5 041 -8 142 70 552 74 838   60 396
Book value, bln rub 18 762 21 749 24 935 28 205 30 000   30 137
EPS, rub ? 76.4 40.5 37.1 40.9 43.1   42.5
FCF/share, rub 61.8 41.3 34.4 34.0 39.0   40.0
BV/share, rub 177.5 203.1 233.7 261.4 286.8   289.8
EBITDA margin, % ? 60.2% 43.2% 35.8% 37.4% 40.6%   38.5%
Net margin, % ? 50.2% 35.6% 30.1% 31.1% 31.4%   29.6%
FCF yield, % ? 9.78% 4.77% 5.05%   6.25%
ROE, % ? 43.0% 19.1% 15.2% 15.0% 14.4%   14.1%
ROA, % ? 31.7% 14.9% 12.0% 11.7% 11.1%   10.8%
P/E ? 8.27 0.00 0.00 17.4 17.9   15.0
P/FCF 10.2 0.00 0.00 21.0 19.8   16.0
P/S ? 4.15 0.00 0.00 5.41 5.63   4.45
P/BV ? 3.56 0.00 0.00 2.73 2.69   2.20
EV/EBITDA ? 6.59 -0.96 -1.73 13.3 12.9   10.5
Debt/EBITDA -0.31 -0.96 -1.73 -1.19 -1.01   -1.05
R&D/CAPEX, % 475.1% 517.9% 430.3% 692.3% 651.2%   730.2%
CAPEX/Revenue, % 3.43% 4.85% 7.06% 5.32% 6.26%   5.75%
Regeneron shareholders